Table 1 Clinical demographics of PCa patients
From: Inflammatory metabolic profile of South African patients with prostate cancer
|  | Treatment-naïve | Post-BO | ||||||
|---|---|---|---|---|---|---|---|---|
Feature | Intermediate, low and very low (n = 14) | High (n = 7) | Very high (n = 12) | Metastatic (n = 1) | Total n = 34) | Non-CRPC (n = 4) | CRPC (n = 3) | Total (n = 7) |
Age (year), median [95% CI] | 65 [56 77] | 70 [52 90] | 64 [57 86] | 75 [75 75] | 68 [63 74] | 72 [63 73] | 66 [64 70] | 70 [65 72] |
Ancestry, n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
 Black | 1 (7.1) | 1 (14.3) | 4 (33.3) | 1 (100.0) | 7 (20.6) | 1 (25.0) | 1 (33.3) | 2 (28.6) |
 Colored | 10 (71.4) | 5 (71.4) | 6 (50.0) | 0 (0.0) | 21 (61.8) | 2 (50.0) | 1 (33.3) | 3 (42.8) |
 Colored/Black | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (25.0) | 0 (0.0) | 1 (14.3) |
 White | 3 (21.4) | 1 (14.3) | 2 (16.7) | 0 (0.0) | 6 (17.6) | 0 (0.0) | 1 (33.3) | 1 (14.3) |
PSA (ng/mL), median [95% CI] | 9 [3 19] | 23 [17 31] | 138 [29 3919] | >5000 | 21 [12 84] | 4 [2 40] | 332 [49 1128] | 34 [4 188] |
Diabetes, n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
 No | 10 (71.4) | 5 (71.4) | 12 (100.0) | 1 (100.0) | 28 (82.4) | 3 (75.0) | 2 (66.7) | 5 (71.4) |
 Yes | 4 (28.6) | 2 (28.6) | 0 (0.0) | 0 (0.0) | 6 (17.6) | 1 (25.0) | 1 (33.3) | 2 (28.6) |
Hypertension, n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
 No | 7 (50.0) | 5 (71.4) | 10 (83.3) | 1 (100.0) | 23 (67.6) | 3 (75.0) | 1 (33.3) | 4 (57.1) |
 Yes | 7 (50.0) | 2 (28.6) | 2 (16.7) | 0 (0.0) | 11 (32.4) | 1 (25.0) | 2 (66.7) | 3 (42.9) |
Smoker, n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
 No | 10 (71.4) | 6 (85.7) | 9 (75.0) | 1 (100.0) | 26 (76.5) | 4 (100.0) | 1 (33.3) | 5 (71.4) |
 Yes | 4 (28.6) | 1 (14.3) | 3 (25.0) | 0 (0.0) | 8 (23.5) | 0 (0.0) | 2 (66.7) | 2 (28.6) |